Estimation of glomerular filtration rate: an evaluation of the use of different equations in the clinical context of older patients

Read full text Summarise with VIRAT
Authors: Andreson Félix da Cruz, Matheus Eduardo do Nascimento Barreto, Francisca Sueli Monte Moreira, Renally Cristina Lima da Silva, Ricardo Brandão, Erika Michelle do Nascimento Facundes Barbosa
Cited by: 0
References: 24

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Objective To verify the level of agreement between the Chronic Kidney Disease Epidemiology Collaboration 2021 (CKD-EPI 2021) and Cockcroft-Gault (CG) equations regarding medication dose adjustment for renal function in older patients, and to analyze whether these estimates imply changes in clinical management. Methods Observational study with a longitudinal and prospective design, including individuals aged 60 years or older, followed during hospitalization. Agreement between dose adjustments based on CKD-EPI 2021 and CG was assessed using the Kappa (κ) test. Results A total of 54 medical records were analyzed, of which the majority were male (53.7%) and younger than 73 years (57.4%). The level of agreement ranged from very good to excellent for atenolol, spironolactone, morphine, metformin, and escitalopram. However, medications such as meropenem, domperidone, piperacillin tazobactam, vancomycin, metoclopramide, regular insulin, and enoxaparin showed moderate to low agreement. In addition, the results indicate that a change in clinical management would occur in 40.40% of the medications that did not present a good level of agreement when one equation or the other was selected. Conclusion There is potential interchangeability between CKD-EPI 2021 and CG for medications that demonstrated a good level of agreement. However, caution is warranted when selecting the equation for medications not included in this group, as the choice may alter clinical management and affect therapeutic effectiveness or increase the risk of toxicity.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Pharmaceutical Practices and Patient Outcomes Antibiotics Pharmacokinetics and Efficacy

Publication details

Journal / source
Revista Brasileira de Geriatria e Gerontologia
Volume
29
Publication date
1 January 2026
Language
EN